Novartis India Share Price
1648.00+33.90 (+2.10%)
+65.55% past 1 Year
Novartis India Limited is a pharmaceutical company. The business operations of the Company include Pharmaceuticals, Generic, over the counter (OTC) and Animal Health. The Pharmaceuticals segment consists of a portfolio
Corporate filings & documents
Announcements
Newspaper Publication made on September 03 2026 in Financial Express and Navshakti for the Intimation sent to the shareholders on September 02 2026 regarding the Notice of the 78th Annual General Meeting scheduled to be held on September 24 2026.
1 day agoNewspaper Publication made on September 03 2026 in Financial Express and Navshakti for the Intimation sent to the shareholders on September 02 2026 regarding the Notice of the 78th Annual General Meeting scheduled to be held on September 24 2026.
1 day agoAnnual Report of Novartis India Limited for FY 2025-26
1 day agoAnnual Report of Novartis India Limited for FY 2025-26
1 day agoNotice of the 78th Annual General Meeting of Novartis India Limited to be held on Thursday September 24 2026 through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
1 day agoNotice of the 78th Annual General Meeting of Novartis India Limited to be held on Thursday September 24 2026 through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
1 day agoBRSR Report of Novartis India Limited for FY 2025-26
1 day agoBRSR Report of Novartis India Limited for FY 2025-26
1 day agoThe Intimation is submitted with BSE regarding the information provided to the Members of the Company for the 78th Annual General Meeting through Newspaper Advertisement
6 days agoThe Intimation is submitted with BSE regarding the information provided to the Members of the Company for the 78th Annual General Meeting through Newspaper Advertisement
6 days agoOutcome of the meeting of the Board of Directors of the Company held on August 17 2026
2 weeks agoOutcome of the meeting of the Board of Directors of the Company held on August 17 2026
2 weeks agoIntimation of the outcome of the Board Meeting held today i.e. August 07 2026
3 weeks agoIntimation of the outcome of the Board Meeting held today i.e. August 07 2026
3 weeks agoDisclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 for the Press Release.
1 month agoDisclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 for the Press Release.
1 month agoOutcome of the 247th meeting of the Board of Directors held today i.e Wednesday July 29 2026.
1 month agoOutcome of the 247th meeting of the Board of Directors held today i.e Wednesday July 29 2026.
1 month agoOutcome of the 246th Board Meeting of the Board of Directors of Novartis India Limited held today i.e Wednesday July 29 2026.
1 month agoOutcome of the 246th Board Meeting of the Board of Directors of Novartis India Limited held today i.e Wednesday July 29 2026.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e Wednesday July 29 2026 took note of the Resignation of Mr. Christopher David Snook as the chairperson of the company.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e Wednesday July 29 2026 took note of the Resignation of Mr. Christopher David Snook as the chairperson of the company.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e Wednesday July 29 2026 took note of the Resignation of the Directors of the company.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e Wednesday July 29 2026 took note of the Resignation of the Directors of the company.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e Wednesday July 26 2026 took note of resignation of Ms. Shilpa Joshi as the Chief Financial Officer of the Company pursuant to the Company Covenant and Warranty Deed.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e Wednesday July 26 2026 took note of resignation of Ms. Shilpa Joshi as the Chief Financial Officer of the Company pursuant to the Company Covenant and Warranty Deed.
1 month agoThe Board of Directors of Novartis India Limited ("the Company) in its meeting today July 29 2026 approved the Change in Control of the Company.
1 month agoThe Board of Directors of Novartis India Limited ("the Company) in its meeting today July 29 2026 approved the Change in Control of the Company.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") at its Meeting held today July 29 2026 approved the Cessation of the exisiting Directors.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") at its Meeting held today July 29 2026 approved the Cessation of the exisiting Directors.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") held today i.e Wednesday July 29 2026 approved the Appointment and Resignation of Directors.
1 month agoThe Board of Directors of Novartis India Limited ("the Company") held today i.e Wednesday July 29 2026 approved the Appointment and Resignation of Directors.
1 month agoDisclosure in terms of Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ("SAST") Regulations 2015.
1 month agoDisclosure in terms of Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ("SAST") Regulations 2015.
1 month agoDisclosure in terms of Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015
1 month agoDisclosure in terms of Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015
1 month agoIntimation under Regulation 31A (10) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations").
1 month agoIntimation under Regulation 31A (10) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations").
1 month agoOutcome of the 245th Meeting of the Board of Directors of Novartis India Limited ("the Company") held today Wednesday July 29 2026.
1 month agoOutcome of the 245th Meeting of the Board of Directors of Novartis India Limited ("the Company") held today Wednesday July 29 2026.
1 month agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for WaveRise Investments Ltd
1 month agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for WaveRise Investments Ltd
1 month agoIntimation of Newspaper Advertisement by Novartis India Limited ("the Company") regarding the publication of Unaudited Financial Results of the Company for the Quarter ended June 30 2026.
1 month agoIntimation of Newspaper Advertisement by Novartis India Limited ("the Company") regarding the publication of Unaudited Financial Results of the Company for the Quarter ended June 30 2026.
1 month agoFinancial Results along with the Limited Review Report of Novartis India Limited for the quarter ended June 30 2026.
1 month agoFinancial Results along with the Limited Review Report of Novartis India Limited for the quarter ended June 30 2026.
1 month agoOutcome of the meeting of the Board of Directors of Novartis India Limited held on Thursday July 23 2026.
1 month agoOutcome of the meeting of the Board of Directors of Novartis India Limited held on Thursday July 23 2026.
1 month agoCertificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 issued to Novartis India Limited ("The Company") by the Registrar to an Issue & Share Transfer Agent ("RTA") of the company.
1 month agoCertificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 issued to Novartis India Limited ("The Company") by the Registrar to an Issue & Share Transfer Agent ("RTA") of the company.
1 month agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-07-23
Dividend
25.0
2024-07-23
Dividend
25.0
2023-07-20
Dividend
10.0
2021-08-17
Dividend
10.0
Company details
Registered office
The Inspire B K C, 7th Floor Bandra Kurla Complex Bandra (East) Mumbai Maharashtra PIN: 400051 Tel No: 022-50243000 Fax No: 022-50243010 Email: [email protected] Internet: www.novartis.in
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Chandni Maru, Company Secretary & Compliance Officer
Ashok Bhatia, Additional Director
Kshitij Sheth, Additional Director
Ramesh Ramadurai, Additional Director
Shashank Sinha, Additional Director
Suchita Sharma, Additional Director
Jagriti Gupta, Additional Director
Details
BSE 500672
NSE NOVARTIND
ISIN INE234A01025